Product
MVA-Mosaic
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV PreventionStatus: Completed, Estimated PCD: 2017-08-29